No takes yet. Share an insight, caveat, or question.
This analysis demonstrates the effect of therapeutic drug monitoring on plasma levels in treatment-resistant schizophrenia, suggesting improved patient outcomes.
Pavel Mohr (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: